Team
We are dedicated to improving the care of cancer patients through rapid on-site tissue imaging and artificial intelligence.
Jay Trautman, PhD
President & CEO, Co-Founder
30+ years in pharmaceutical, medical device and life-science R&D and commercialization
​
Co-founded 5 companies, 4 have exited
​
Vedere Bio acquired by Novartis for $280M; Praelux sold to Amersham/GE
​
Started career at Bell Labs
Chris Freudiger, PhD
Chief Technology Officer, Co-Founder
18+ years in biomedical and medical devices
​
World-renowned spectroscopist and artificial intelligence expert, 10k+ citations, 10+ artificial intelligence image analysis publications
​
Discovered SRH at Harvard, led engineering of the NIO Laser Imaging System and artificial intelligence, led early commercialization with KOLs
Steven Pastore, MD
VP of Clinical Affairs
5+ years in pathology and medical devices
​
Obtained MD at Zucker School of Medicine, completed 18 months of pathology residency at Northwell Health
​
Serves as SRH pathology expert, leads clinical studies, and liaison for commercialization and artificial intelligence development
Adrian Ion-Margineanu, Dual PhD
Head of Artificial Intelligence Development
10+ years in artificial intelligence/machine learning and biomedical imaging, dual PhD in Machine and Deep Learning
​
Marie Curie Fellow with 19 published and peer-reviewed papers on artificial intelligence/machine learning/deep learning, ex-Phillips where he developed deep learning algorithms for tumor cell detection in H&E and IHC microscopy images.
​
Leads artificial intelligence development at Invenio, developing AI for brain cancer (CE-marked), lung cancer, and prostate cancer
Geoff Maniago
Manager of Manufacturing
20+ years manufacturing and developing complex laser systems
​
Ex-Coherent (scientific & high power lasers) and Enablence Tech (telecom), experience in ISO-13485 quality systems
​
Leads in-house manufacturing of the NIO Laser Imaging System, 20+ systems completed